Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

WT, ∆rhlB and ∆rppH mRNA half-life profiling.

ABSTRACT: WT, ∆rhlB and ∆rppH mRNA half-life profiling.

PROVIDER: PRJNA950407 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24030210.fastq.gz	Fastqsanger.gz
	SRR24030211.fastq.gz	Fastqsanger.gz
	SRR24030212.fastq.gz	Fastqsanger.gz
	SRR24030213.fastq.gz	Fastqsanger.gz
	SRR24030214.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

WT, ∆rhlB and ∆rppH mRNA half-life profiling.

Project description:WT, ∆rhlB and ∆rppH strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. Wild type(WT) was compared to ∆rhlB (deleted RNA helicase RhlB gene) and ∆rppH (deleted RppH gene) strains

2023-04-03 | GSE228592 | GEO

Cell cycle mRNA half-life profiling.

Project description:Cell cycle mRNA half-life profiling.

| PRJNA950409 | ENA

WT and RNE∆IDR mRNA half-life profiling in Sinorhizobium meliloti.

Project description:WT and RNE∆IDR mRNA half-life profiling in Sinorhizobium meliloti.

| PRJNA1055090 | ENA

BR-body mutant mRNA half-life profiling.

Project description:BR-body mutant mRNA half-life profiling.

| PRJNA551694 | ENA

WT and RNE∆IDR mRNA half-life profiling in Sinorhizobium meliloti.

Project description:WT and RNE∆IDR strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. Wild type(WT) was compared to RNE∆IDR strain.

2023-12-25 | GSE251703 | GEO

Retapamullin and Chloramphenicol treated mRNA half-life profiling.

Project description:Retapamullin and Chloramphenicol treated mRNA half-life profiling.

| PRJNA950406 | ENA

Cell cycle mRNA half-life profiling.

Project description:mRNA half-life profiling in the bacterium Caulobacter crescentus was performed in synchronized cells collected from different stages of the cell cycle including swarmer cells, stalk cells (45 min post synchrony), and predivisional cells (90 min post synchrony). For each cell population, transcription was disrupted by the antibiotic rifampicin, and RNA samples were collected at different time points to measure the mRNA half-lives.

2023-04-03 | GSE228593 | GEO

Retapamullin and Chloramphenicol treated mRNA half-life profiling.

Project description:mRNA half-life profiling in the bacterium Caulobacter crescentus was performed in cells that were inhibited in translation initiation (retapamullin) or elongation (chloramphenicol) by shutting of transcription with the antibiotic rifampicin, and following mRNA abundance at 1, 2, 4, 8, and 15 minutes post rifampicin. All RNA measurements were performed on cells grown to mid-log in M2G minimal growth medium. Two biological replicates time coursees were collected from independent starter cultures.

2023-04-03 | GSE228591 | GEO

Global mRNA half-lives measurement in nonsense-mediated mRNA decay deficient ESCs

Project description:Nonsense-mediated mRNA decay (NMD) pathway promotes the degradation of several mRNA species, including transcripts containing a premature termination codon. Here,we measured global mRNA half-lives in NMD deficient and wild-type (WT) embryonic stem cells (ESCs). This allowed us to discriminate which transcripts are affected by NMD. Several transcripts had an impaired half-life in Smg5 and Smg6 KO ESCs compared to WT. They belong to different pathways and cellular processing indicating that NMD regulates multiple processes in the cells. Finally, majority of the transcripts had an impairment on the half-life in both Smg5 and Smg6 KO ESCs indicating that endo- and exonucleolityc branches of the NMD pathway target the same mRNAs.

2022-02-02 | GSE153455 | GEO

BR-body mutant mRNA half-life profiling.

Project description:BR-body mutant strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. JS38 (wild type) was compared to JS221 (lacking the intrinsically disordered CTD and unable to form BR-bodies), JS233 (unable to recruit degradosome components into BR-bodies), and JS299 (active site mutant of RNase E).

2019-06-29 | GSE133532 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data